FDA Investigator Albert F Peacock, PhD
Albert F Peacock, PhD has inspections in 2 countries as of 22 Sep 2023. Albert F Peacock, PhD has collaborated with a combinined 2883 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
200
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Switzerland
Co-Investigator(s):
Abby Lmozeke Baker,
Adam C Hipko,
Albert Peacock, PhD,
Amanda J White,
Amy A Johnson,
Andrea A Branche,
Anya D Lockett Evans,
Ashley N Williams,
Audrey J Yarbrough,
Blondell W Johnson,
Bobbi J Miller,
Bonnie L Menzel,
Brenda G Stewart Munoz,
Brian Sanders,
Burnell M Henry,
Carol F Robinson,
Carol Mrivera Lopez, PhD,
Carolyn A Pinney,
Charles B Steinmiller,
Charles D Brown,
Christopher J Smith,
Cody D Rickman,
Connie Hannon Rabel,
Connie L Hannon Rabel,
Cordelia J Brammer,
Cynthia Jim, CSO,
Darla J Christopher,
David M Beltran,
Dawn C Olenjack,
Deborah S Hammond,
Decarlos A Gomez,
Deniza Karacic,
Dennis R Hudson,
Destry M Sillivan,
Dr. Jason R Caballero,
Dr. Sriram Subramaniam, PhD,
Ed Gonzalez Vazquez,
Eliezar Ramos,
Elizabeth D Connell,
Ellen J Tave,
Elmina E Akwo,
Elmina E Mboh,
Elvia J Cervantes,
Emily B Camire,
Emily S Mcgann,
Enspect User,
Eric T Huebler,
Eric W Lacour,
Erma Zaimova,
Ernest Serna, III,
Esther A Ofori,
Everard A Irish,
Frans E Mercado,
Frederic W French, III,
Garrad R Poole,
Gene D Arcy,
Gloria A Milster,
Grant,
Habacuc V Barrera,
Henry E Sanchez,
Hoimay Chan,
Hugh M Mcclure, II,
Hung V Le,
Iris C Macinnes,
Ismael Olvera, IV,
Jacqueline A O'shaughnessy, PhD,
James H Robinson,
Janet B Abt,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer A Kemp,
Jennifer D Young,
Jennifer Hua,
Jocelyn C Turner,
Jodi M Gatica,
Joel D Martinez,
John A Kadavil, PhD,
Jose Martinez, Jr,
Judy Ellen Ciaraldi,
Julia D Cartwright,
Kari M Johansen,
Karlton T Watson,
Kathleen B Swat,
Kenneth L Smalls,
Kip J Hanks,
Laressa R Gray,
Latorie S Jones,
Laura E Garcia,
Lauren E Skokan,
Lauren M Lilly, PhD,
Laurie A Haxel,
Leigh Anne Myers,
Leighton K Ngai,
Lesley Maep Lutao,
Lillie M Young,
Lisa M Pence,
Lisa M Puttonen,
Lisa R Jennings,
Lisa R Whitt,
Lorie S Hannappel,
Lourdes R Genera,
Luis A Salinas,
Lynnette I Riggio,
Maira P Brading,
Marc A Jackson, Jr,
Marion W Nadeau,
Mark A Guerra,
Martin K Yau, PhD,
Martinez,
Matthew J Gretkierewicz,
Merelynn Rhoten,
Michele L Forster, PhD,
Michelle Paxon,
Mihaly S Ligmond,
Monica Y Yu,
Monique S Frazier,
Mpris Inspector,
Nancy T Waites,
Nikisha M Bolden,
Nimmy Mathews,
Patricia M Jacobs,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paul M Chefor,
Paula A Trost,
Paula J Perry,
Pauline N Logan,
Peter Kessler, PhD,
Prabhu P Raju,
Ramon L Gonzalez Prieto,
Randa Melhem, PhD,
Rene R Ramirez,
Rhonda L Dash,
Richard J Bashay,
Richard L Bartlett,
Richard T Riggie,
Robert Barron,
Robert M Tillman,
Ronda R Loyd,
Ronda R Loyd Jones,
Rose Ashley,
Rose M Ashley,
Sam H Haidar, PhD,
Scott T Ballard,
Sha'tina R Alridge,
Sidney B Priesmeyer,
State Agency,
Stephen D Brown,
Sunitha K Rajaram, PhD,
Terrance L Thomas,
Theressa B Smith,
Toby Vern H Hill,
Tracy J Washington,
Travis R Hunt,
Tricia S Martinez,
Virginia Ramos,
Vivian Garcia,
William F Lagud, Jr,
Xikui Chen (nmi), PhD,
Yaw O Osei,
Yiping Jia,
Young M Yoon,
Zerita White
Albert F Peacock, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2003 | FDA 483 | Aventis Bio-Services, Inc - Form 483, 2003-07-29 |
May, 2002 | FDA 483 Response | South Texas Blood & Tissue Center - Form 483R, 2002-05-28 |
July, 2010 | FDA 483 | Bio-Medical Pharmaceutical Manufacturing Corporation - Form 483, 2010-07-09 |
August, 2002 | EIR | Carter BloodCare - EIR, 2002-08-02 |
March, 2002 | FDA 483 | Gulf Coast Regional Blood Center - Form 483, 2002-03-01 |
April, 2010 | EIR | Stillmeadow Incorporated - EIR, 2010-04-28 |
December, 2010 | FDA 483 | Cetero Research - Form 483, 2010-12-10 |
March, 2002 | FDA 483 Response | Gulf Coast Regional Blood Center - Form 483R, 2002-03-12 |
May, 2002 | EIR | South Texas Blood & Tissue Center - EIR, 2002-05-28 |
August, 2002 | EIR | Oklahoma Blood Institute - Sylvan N Goldman Center - EIR, 2002-08-30 |
June, 2002 | EIR | Grifols Biomat USA, Inc. - EIR, 2002-06-26 |
November, 2000 | EIR | Gulf Coast Regional Blood Center - EIR, 2002-03-01 |
May, 2002 | FDA 483 | South Texas Blood & Tissue Center - Form 483, 2002-05-28 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more